A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- Vaccination obligation, Bassetti: “From Draghi a strong and right choice” Sep 2, 2021
- Named a way to lose weight without starving May 6, 2020
- “Important covid vaccine but don’t forget the other vaccinations” Jul 8, 2021
- Minus 10 pounds: how to lose weight on the watermelon diet Jul 26, 2020
- Debunked popular myths about separate nutrition Jun 29, 2020
- Medicines: Is the shortage of amoxicillin endangering the health of our children? Nov 18, 2022
- AI could help counter the spread of disinformation campaigns May 31, 2021